What is Sinopharm Group Co Cash Flow from Investing?
Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).
For the
six
months ended in Dec. 2024, Sinopharm Group Cospent$93 Mil on purchasing property, plant, equipment.
It gained$-5 Mil from selling property, plant, and equipment.
It spent$16 Mil on purchasing business.
It gained$8 Mil from selling business.
It spent$-10 Mil on purchasing investments.
It gained$1 Mil from selling investments.
It received$1 Mil from net Intangibles purchase and sale.
And it paid$277 Mil for other investing activities.
In all, Sinopharm Group Cospent$373 Mil on investment activities in financial market and operating subsidiaries for the
six
months ended in Dec. 2024.
Sinopharm Group Co Cash Flow from Investing Historical Data
The historical data trend for Sinopharm Group Co's Cash Flow from Investing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co Cash Flow from Investing Calculation
Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).
If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).
Likewise, if a company buys another company for cash, this will reduce their cash position.
Sinopharm Group Co's Cash Flow from Investing for the fiscal year that ended in Dec. 2024 is calculated as:
Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-516 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co (OTCPK:SHTDY) Cash Flow from Investing Explanation
Sinopharm Group Co's purchase of property, plant, equipment for the
six
months ended in Dec. 2024 was $-93 Mil. It means Sinopharm Group Co spent $93 Mil on purchasing property, plant, equipment.
In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.
In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Sinopharm Group Co's sale of property, plant, equipment for the
six
months ended in Dec. 2024 was $-5 Mil. It means Sinopharm Group Co gained $-5 Mil from selling property, plant, and equipment.
3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.
Sinopharm Group Co's purchase of business for the
six
months ended in Dec. 2024 was $-16 Mil. It means Sinopharm Group Co spent $16 Mil on purchasing business.
4. Sale Of Business:
Sale of business indicates the amount gained from selling business.
Sinopharm Group Co's sale of business for the
six
months ended in Dec. 2024 was $8 Mil. It means Sinopharm Group Co gained $8 Mil from selling business.
5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.
Sinopharm Group Co's purchase of investment for the
six
months ended in Dec. 2024 was $10 Mil. It means Sinopharm Group Co spent {stock_data.stock.currency_symbol}}-10 Mil on purchasing investments.
6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.
Sinopharm Group Co's sale of investment for the
six
months ended in Dec. 2024 was $1 Mil. It means Sinopharm Group Co gained $1 Mil from selling investments.
7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.
Sinopharm Group Co's net Intangibles purchase and sale for the
six
months ended in Dec. 2024 was $1 Mil.
It means Sinopharm Group Co received $1 Mil from net Intangibles purchase and sale.
8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.
Sinopharm Group Co's cash from discontinued investing activities for the
six
months ended in Dec. 2024 was 0 Mil.
It means Sinopharm Group Co paid $0 Mil for discontinued investing activities.
9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.
Sinopharm Group Co's cash from other investing activities for the
six
months ended in Dec. 2024 was $-277 Mil.
It means Sinopharm Group Co paid $277 Mil for other investing activities.
Sinopharm Group Co Cash Flow from Investing Related Terms
Thank you for viewing the detailed overview of Sinopharm Group Co's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHTDY has been successfully added to your 